Approximately 60–70% of breast cancers are estrogen receptor (ER) or progesterone receptor (PR) positive, and 15–30% of cases have gene amplification and overexpression of the human epidermal growth factor receptor 2 (HER2) protein [2]. This evidence concerns the gene ERBB2 and breast carcinoma.